School of Biochemistry and Immunology, Trinity College, Dublin 2, Ireland.
J Neural Transm (Vienna). 2011 Jul;118(7):1079-89. doi: 10.1007/s00702-011-0611-z. Epub 2011 Mar 4.
Tissue bound primary amine oxidase (PrAO) and its circulating plasma-soluble form are involved, through their catalytic activity, in important cellular roles, including the adhesion of lymphocytes to endothelial cells during various inflammatory conditions, the regulation of cell growth and maturation, extracellular matrix deposition and maturation and glucose transport. PrAO catalyses the oxidative deamination of several xenobiotics and has been linked to vascular toxicity, due to the generation of cytotoxic aldehydes. In this study, a series of amines and aldehydes contained in food and drugs were tested via a high-throughput assay as potential substrates or inhibitors of bovine plasma PrAO. Although none of the compounds analyzed were found to be substrates for the enzyme, a series of molecules, including caffeine, the antidiabetics phenformin and tolbutamide and the antimicrobial pentamidine, were identified as PrAO inhibitors. Although the inhibition observed was in the millimolar and micromolar range, these data show that further work will be necessary to elucidate whether the interaction of ingested biogenic or xenobiotic amines with PrAO might adversely affect its biological roles.
组织结合型原发性胺氧化酶(PrAO)及其循环血浆可溶性形式通过其催化活性参与重要的细胞功能,包括淋巴细胞在各种炎症条件下与内皮细胞的黏附、细胞生长和成熟的调节、细胞外基质沉积和成熟以及葡萄糖转运。PrAO 催化几种外源物的氧化脱氨作用,由于生成细胞毒性醛,与血管毒性有关。在这项研究中,通过高通量测定法测试了食品和药物中含有的一系列胺和醛,以评估它们是否为牛血浆 PrAO 的潜在底物或抑制剂。尽管未发现分析的化合物中有任何一种是该酶的底物,但鉴定出了一系列分子,包括咖啡因、抗糖尿病药物苯乙双胍和甲苯磺丁脲以及抗菌药物戊双脒,它们是 PrAO 的抑制剂。尽管观察到的抑制作用处于毫摩尔和微摩尔范围内,但这些数据表明,需要进一步研究,以阐明摄入的生物源或外源胺与 PrAO 的相互作用是否可能对其生物学功能产生不利影响。